mortality/aging
• after intraperitoneal injection of tamoxifen mice need to be euthanized within 5 days of the development of the abnormal skin phenotype
|
endocrine/exocrine glands
• seen after tamoxifen treatment
|
growth/size/body
weight loss
(
J:153292
)
• seen after the development of the abnormal skin phenotype induced by intraperitoneal injection of tamoxifen
|
homeostasis/metabolism
• in tamoxifen treated mice, progressive increase in trans epidermal water loss is seen coinciding with the appearance and progression of the scaly skin phenotype
|
immune system
• moderate inflammation is seen in the early stages of phenotype development after topical treatment with tamoxifen
|
integument
• seen after tamoxifen treatment
|
• in tamoxifen treated mice, progressive increase in trans epidermal water loss is seen coinciding with the appearance and progression of the scaly skin phenotype
|
• moderate inflammation is seen in the early stages of phenotype development after topical treatment with tamoxifen
|
• after tamoxifen treatment hair follicles appear distended
|
• at later stages after tamoxifen treatment hair follicles disappear
|
• seen after tamoxifen treatment
|
• seen after tamoxifen treatment
|
acanthosis
(
J:153292
)
• seen after tamoxifen treatment
|
scaly skin
(
J:153292
)
• after tamoxifen treatment mice develop scales that first appear on the ventral side and snout then extend to the back and whole body
|
• after topical tamoxifen treatment ulcerations appear associated with shedding of large scale and complete loss of the epidermis
|